共 197 条
[1]
Bharucha T(2015)Sudden death in childhood cardiomyopathy: results from a long-term national population-based study J Am Coll Cardiol 65 2302-2310
[2]
Lee KJ(2018)Risk marker profiles in patients treated with percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy Clin Res Cardiol 107 479-486
[3]
Daubeney PE(2013)Cardiovascular magnetic resonance characteristics in children with hypertrophic cardiomyopathy Circ Heart Fail 6 1013-1020
[4]
Nugent AW(2007)Epidemiology and cause-specific outcome of hypertrophic cardiomyopathy in children: findings from the Pediatric Cardiomyopathy Registry Circulation 115 773-781
[5]
Turner C(2018)The T-peak-to-T-end interval: a novel ECG marker for ventricular arrhythmia and appropriate ICD therapy in patients with hypertrophic cardiomyopathy Clin Res Cardiol 107 130-137
[6]
Sholler GF(2010)Research priorities in hypertrophic cardiomyopathy: report of a Working Group of the National Heart, Lung, and Blood Institute Circulation 122 1130-1133
[7]
Robertson T(2011)RAS signaling pathway mutations and hypertrophic cardiomyopathy: getting into and out of the thick of it J Clin Investig 121 844-847
[8]
Justo R(2015)Rapidly progressive hypertrophic cardiomyopathy in an infant with Noonan syndrome with multiple lentigines: palliative treatment with a rapamycin analog Am J Med Genet Part A 167A 744-751
[9]
Ramsay J(2012)Hypertrophic cardiomyopathy in childhood: disease natural history, impact of obstruction, and its influence on survival Ann Thoracic Surg 93 840-848
[10]
Carlin JB(2016)Pharmacological treatments for Friedreich ataxia Cochrane Database Syst Rev 382 1889-1897